Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
Al B. Benson(Northwestern University), Frankie Jones(National Comprehensive Cancer Network), Smitha Krishnamurthi(Cleveland Clinic), Christina Wu(Mayo Clinic Hospital), Aparna Parikh(Massachusetts General Hospital), Benjamin D. Shogan(University of Chicago), Hitendra Patel(UC San Diego Health System), Christopher G. Willett, David Shibata(St. Jude Children's Research Hospital), Jeffrey A. Meyerhardt(CancerCare), Ignacio Garrido‐Laguna(University of Utah), Natalie Kirilcuk, Sarah E. Hoffe(Moffitt Cancer Center), Mary F. Mulcahy(Northwestern University), Leonard B. Saltz(Memorial Sloan Kettering Cancer Center), Alan P. Venook(University of California, San Francisco), Anna Tavakkoli(Southwestern Medical Center), Eric D. Miller(The Ohio State University), Jean L. Grem(National Cancer Institute), Dustin A. Deming(University of Wisconsin–Madison), George J. Chang(The University of Texas MD Anderson Cancer Center), Mohamed A. Adam(Duke University), Kristen K. Ciombor(Vanderbilt University Medical Center), Midhun Malla(University of Alabama at Birmingham), Kimberly L. Johung(Yale University), Charles Schneider(University of Pennsylvania), Steven Nurkin(Barnes-Jewish Hospital), Stacey A. Cohen(Fred Hutch Cancer Center), Hisham Hussan(The Ohio State University), Jenna Snedeker(National Comprehensive Cancer Network), Constantinos T. Sofocleous(Memorial Sloan Kettering Cancer Center), Wells A. Messersmith(University of Colorado Cancer Center), Paul Haste(Indiana University Melvin and Bren Simon Comprehensive Cancer Center), Jennifer K. Maratt(Indiana University Melvin and Bren Simon Comprehensive Cancer Center), Harry S. Cooper(Fox Chase Cancer Center), Steven R. Hunt(Washington University in St. Louis), Katrina S. Pedersen(Mayo Clinic in Arizona), Lisa A. Gurski(National Comprehensive Cancer Network), Yi-Jen Chen(City Of Hope National Medical Center), J. Randolph Hecht(Ontario Institute for Cancer Research), John M. Skibber(The University of Texas MD Anderson Cancer Center), Nora Joseph, Michael J. Overman(The University of Texas MD Anderson Cancer Center)
Cited by 333
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k